Curetis N.V. (the "Company" and, together with Curetis USA Inc. and Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that the Company is going to attend several industry conferences in the second quarter of 2018.
April:
H.C. Wainwright Global Life Sciences Conference, April 8-9, 2018 – Monte Carlo, Monaco – company presentation and one-on-one investor meetings.
9th Deutsche Biotechnologietage, April 18-19, 2018 – Berlin, Germany – company presentation and panel discussion.
Kempen Life Sciences Conference, April 18-19, 2018 – Amsterdam, The Netherlands – company presentation and one-on-one investor meetings.
28th ECCMID 2018, April 21-24, 2018 – Madrid, Spain; IFEMA – Feria de Madrid: Booth 79.
May:
ASM Clinical Virology Symposium, May 6-9, 2018 – West Palm Beach, FL, USA, Palm Beach County Convention Center: booth 223, corporate workshop and poster.
21th Annual MAD-ID Meeting, May 9-12, 2018 – Orlando, FL, USA.
BioEquity Europe, May 14-16 - Ghent, Belgium– company presentation and one-on-one investor meetings.
ATS 2018 – May 18-23, 2018 – San Diego, CA, USA; San Diego Convention Center: booth 605, poster.
June:
ASM Microbe 2018, June 7-11, 2018 – Atlanta, GA USA; Georgia World Congress Center: booth 2323, industry forum, corporate workshop and poster.
Goetzpartners Healthcare Day, June 22, 2018 – London, UK – company presentation and one-on-one investor meetings.